Ciclopirox and Prolia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ciclopirox (ciclopirox) and Prolia (denosumab). Common drug interactions include procedural complication among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Ciclopirox and Prolia. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Ciclopirox?

Ciclopirox has active ingredients of ciclopirox. eHealthMe is studying from 2,646 Ciclopirox users. Check the latest studies of Ciclopirox.

What is Prolia?

Prolia has active ingredients of denosumab. It is often used in osteoporosis. eHealthMe is studying from 151,388 Prolia users. Check the latest studies of Prolia.



On Jul, 20, 2026

14 people who take Ciclopirox and Prolia together, and have interactions are studied.

Ciclopirox and Prolia drug interactions.

What are the common drug interactions of Ciclopirox and Prolia, by gender? *:

female:

  1. Procedural complication
  2. Protein urine present
  3. Pulmonary mass
  4. Rash
  5. Rash macular (small, flat red spots)
  6. Rib fracture
  7. Rosacea (a skin condition that causes facial redness)
  8. Scab (a hard coating on the skin formed during the wound healing)
  9. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  10. Scratch

male:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Emotional distress
  4. Eye pain
  5. Multiple fractures
  6. Myasthenia gravis crisis (a paralysis of the respiratory muscles occurs)
  7. Pain
  8. Pain in extremity
  9. Pruritus (severe itching of the skin)
  10. Upper respiratory tract infection

What are the common drug interactions of Ciclopirox and Prolia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Intervertebral disc degeneration (spinal disc degeneration)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Plantar fascial fibromatosis (non-malignant thickening of the feet's deep connective tissue)
  4. Rib fracture
  5. Upper respiratory tract infection
  6. Vitamin d deficiency
  7. Anaemia (lack of blood)
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Compression fracture (fracture due to pressure caused by injury)
  10. Death

60+:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Abdominal distension
  4. Abdominal pain
  5. Accident at home
  6. Anaemia (lack of blood)
  7. Aphonia (inability to produce voice)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  10. Blood cholesterol increased

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 3 people, 21.43%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 14.29%
  3. Pain: 2 people, 14.29%
  4. Fungal Infection: 2 people, 14.29%
  5. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 7.14%
  6. Fungal Nail Infection: 1 person, 7.14%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 7.14%
  8. Erection Problems: 1 person, 7.14%
  9. Enthesopathy (disorder of entheses (bone attachments)): 1 person, 7.14%
  10. Dyspnea (difficult or laboured breathing): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ciclopirox and Prolia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ciclopirox and Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ciclopirox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ciclopirox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prolia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciclopirox and denosumab (the active ingredients of Ciclopirox and Prolia, respectively), and Ciclopirox and Prolia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: